Hayashi Y, Tsukada M, Shinoda D, Matsui M, Iwama K, Kajiwara K, et al. Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis. J Hematol [Internet]. 2025 Apr. 26 [cited 2025 May 19];14(2):66-73. Available from: https://jh.elmerpub.com/jh/article/view/2010